Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AB Science S.A. stock logo
ABSCF
AB Science
$1.60
$1.58
$0.80
$1.60
N/AN/A640 shsN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
$0.00
-3.6%
$0.01
$0.00
$0.15
N/AN/A1.27 million shs87,628 shs
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
$0.00
$0.00
$0.00
$0.02
N/AN/A11,509 shs298 shs
1933 Industries Inc. stock logo
TGIFF
1933 Industries
$0.00
-20.0%
$0.00
$0.00
$0.02
N/AN/A111,760 shs20,750 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AB Science S.A. stock logo
ABSCF
AB Science
0.00%0.00%+1.91%+77.78%-40.74%
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
-3.57%+8.00%-32.50%-81.88%-96.98%
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
0.00%-39.29%-45.16%+30.77%-69.75%
1933 Industries Inc. stock logo
TGIFF
1933 Industries
-20.00%-2.04%+14.29%+77.78%-55.14%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AB Science S.A. stock logo
ABSCF
AB Science
N/AN/AN/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/AN/AN/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/AN/AN/AN/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AB Science S.A. stock logo
ABSCF
AB Science
0.00
N/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
0.00
N/AN/AN/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
0.00
N/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AB Science S.A. stock logo
ABSCF
AB Science
N/AN/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/AN/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/AN/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AB Science S.A. stock logo
ABSCF
AB Science
N/AN/A0.00N/AN/AN/AN/A5/13/2025 (Estimated)
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/A0.00N/AN/AN/AN/AN/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/AN/A0.00N/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AB Science S.A. stock logo
ABSCF
AB Science
N/AN/AN/AN/AN/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/AN/AN/AN/AN/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AB Science S.A. stock logo
ABSCF
AB Science
N/A
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
N/A
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
N/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AB Science S.A. stock logo
ABSCF
AB Science
51N/AN/ANot Optionable
4Front Ventures Corp. stock logo
FFNTF
4Front Ventures
460N/AN/ANot Optionable
Mydecine Innovations Group Inc. stock logo
MYCOF
Mydecine Innovations Group
3N/AN/ANot Optionable
1933 Industries Inc. stock logo
TGIFF
1933 Industries
87N/AN/ANot Optionable

Recent News About These Companies

1933 sees uptick in revenue in Nevada
1933 Industries Appoints New CFO and VP Finance
1933 gets bumped down to the pink sheets
1933 Industries to Trade on the Pink Open Market
Look Back: 1933 flooding trapped miners in Nanticoke

New MarketBeat Followers Over Time

Media Sentiment Over Time

AB Science stock logo

AB Science OTCMKTS:ABSCF

$1.60 0.00 (0.00%)
As of 05/9/2025

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

4Front Ventures stock logo

4Front Ventures OTCMKTS:FFNTF

$0.0027 0.00 (-3.57%)
As of 05/12/2025 03:53 PM Eastern

4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.

Mydecine Innovations Group stock logo

Mydecine Innovations Group OTCMKTS:MYCOF

$0.0034 0.00 (0.00%)
As of 05/12/2025 12:06 PM Eastern

Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

1933 Industries stock logo

1933 Industries OTCMKTS:TGIFF

$0.0048 0.00 (-20.00%)
As of 05/12/2025 12:01 PM Eastern

1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada.